In the News

207 News Items found
MSK patient Charisma McDuffie is seen smiling outdoors.
Learn about the latest research on why more young adults are developing cancer, from investigators across MSK.
Memorial Sloan Kettering neuro-oncologist Adrienne Boire
Roundup
Read about some of the most important clinical advances made at MSK in 2020.
Andrea Cercek, MD, co-director of the Center for Young Onset Colorectal Cancer at MSK
An uptick in colorectal cancer in people under the age of 50 is an alarming trend that led Memorial Sloan Kettering to develop the first of its kind Center for Young Onset Colorectal Cancer in 2018. Read more.
immunofluorescence image of colorectal cancer cells
Metastasis remains the primary challenge to reducing cancer deaths worldwide. A new MSK study is providing unique insights that researchers say point to new therapeutic opportunities.
Roxanne Joseph
New Leads in an Unsolved Mystery
After treatment for rectal cancer, Roxanne Joseph is back to enjoying an active life with her husband, Rory, and their two children. Recent research by MSK computational biologist Henry Walch is shedding light on why colorectal cancer has been more difficult to treat in many Black people.
Diane Reidy-Lagunes
A team of experts at Memorial Sloan Kettering shared their insights on colorectal cancer and general digestive health in an Information Session for patients, caregivers and those at increased risk for the disease.
An MSK researcher reviews images on a screen
MSK Research Highlights, September 14, 2026
New MSK research shows how a metabolite boosts immune cells against cancer; adds to the understanding of how colorectal cancer spreads; reveals tumor CD19 levels may predict the success of CAR T cell therapy; and finds a new targeted drug combination shows promise in early trial for small cell lung cancer.
a researcher holds a sign reading "Proud to be an MSK scientist"
Top Cancer Research Advances at MSK in 2023
Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.
An MSK scientist peers through a microscope
New MSK research finds adherence is a hurdle for home-based colorectal cancer tests; sheds new light on tumor-associated macrophages in glioblastoma; identifies statins as a promising addition to treatment for HER2-positive gastric cancer; and describes how a new single-cell transcriptome atlas opens the “black box” of early human embryo development.
AACR sign
Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses.